Back
Genprex Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
14
GNPX
Genprex
Last Price:
2.09
Seasonality Move:
43.77%
Buy
97
RYTM
Rhythm Pharmaceuticals
Last Price:
64.04
Seasonality Move:
9.98%
Sell
14
Genprex (GNPX)
is a Sell
Is Genprex a Buy, Sell or Hold?
- The current Genprex [GNPX] share price is $1.34. The Score for GNPX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- GNPX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
97
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $65.58. The Score for RYTM is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $65.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
GNPX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 47.72 | Sell |
| Chaikin Money Flow: | -361799 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.52 - 2.4) | Sell |
| Bollinger Bands (100): | (0.47 - 2.01) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.64 | Buy |
| Relative Strength Index (14 RSI): | 75.47 | Buy |
| Chaikin Money Flow: | -747845 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.34 - 58.08) | Buy |
| Bollinger Bands (100): | (43.86 - 53.38) | Buy |
GNPX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.8 | Sell |
| 20-day SMA: | 1.74 | Sell |
| 50-day SMA: | 0.94 | Buy |
| 200-day SMA: | 2.38 | Sell |
| 8-day EMA: | 1.7 | Sell |
| 20-day EMA: | 1.62 | Sell |
| 50-day EMA: | 1.3 | Buy |
| 200-day EMA: | 4.4 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.17 | Buy |
| 20-day SMA: | 53.22 | Buy |
| 50-day SMA: | 51.3 | Buy |
| 200-day SMA: | 45.17 | Buy |
| 8-day EMA: | 60.15 | Buy |
| 20-day EMA: | 55.23 | Buy |
| 50-day EMA: | 51.77 | Buy |
| 200-day EMA: | 44.82 | Buy |
Genprex Earnings Growth & GNPX Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $18.50 per share, and an increase next year of $3.37 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Genprex Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||